Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension

Circulation: Cardiovascular Interventions

Volumn 8, Issue 11, 2015, Pages

  Rothman, Alexander M K ^a,c   Arnold, Nadine D ^a   Chang, William ^d   Watson, Oliver ^a   Swift, Andrew J ^b,c   Condliffe, Robin ^e   Elliot, Charlie A ^e   Kiely, David G ^e   Suvarna, S Kim ^a   Gunn, Julian ^a,c   Lawrie, Allan ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Academic Unit of Radiology   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d MEDTRONIC INC   (United States)

^e ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

ablation techniques; hypertension; nervous system; pulmonary; pulmonary artery; pulmonary circulation

Indexed keywords

THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY WALL; ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HISTOLOGY; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG SURGERY; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY CATHETER; PULMONARY ARTERY DENERVATION; PULMONARY HYPERTENSION; RADIOFREQUENCY; SWAN GANZ CATHETER; VASOCONSTRICTION; ACUTE DISEASE; ANIMAL; AUTONOMIC NERVE; BLOOD PRESSURE; CATHETER ABLATION; DENERVATION; DISEASE MODEL; HEMODYNAMICS; HUMAN; HYPERTENSION, PULMONARY; INNERVATION; METABOLISM; PATHOLOGY; PIG; SURGERY; VASCULAR RESISTANCE;

ACUTE DISEASE; ANIMALS; AUTONOMIC PATHWAYS; BLOOD PRESSURE; CARDIAC OUTPUT; CATHETER ABLATION; DENERVATION; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; PULMONARY ARTERY; SWINE; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 84947803671     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.002569     Document Type: Article

References (17)

1. Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, Billings C, Lawrie A, Sabroe I, Akil M, O'Toole L, Kiely DG. ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J. 2012;39:945-955. doi: 10.1183/09031936.00078411.
2. Galiè N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62(25 suppl):D60-D72. doi: 10.1016/j.jacc.2013.10.031.
3. Nootens M, Kaufmann E, Rector T, Toher C, Judd D, Francis GS, Rich S. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol. 1995;26:1581-1585. doi: 10.1016/0735-1097(95)00399-1.
4. Mak S, Witte KK, Al-Hesayen A, Granton JJ, Parker JD. Cardiac sympathetic activation in patients with pulmonary arterial hypertension. Am J Physiol Regul Integr Comp Physiol. 2012;302:R1153-R1157. doi: 10.1152/ajpregu.00652.2011.
5. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110:1308-1312. doi: 10.1161/01. CIR.0000140724.90898.D3.
6. Ciarka A, Doan V, Velez-Roa S, Naeije R, van de Borne P. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1269-1275. doi: 10.1164/rccm.200912-1856OC.
7. Crnkovic S, Egemnazarov B, Jain P, Seay U, Gattinger N, Marsh LM, Bálint Z, Kovacs G, Ghanim B, Klepetko W, Schermuly RT, Weissmann N, Olschewski A, Kwapiszewska G. NPY/Y receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol. 2014;171:3895-3907. doi: 10.1111/bph.12751.
8. Juratsch CE, Jengo JA, Castagna J, Laks MM. Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature. Chest. 1980;77:525-530.
9. Osorio J, Russek M. Reflex changes on the pulmonary and systemic pressures elicited by stimulation of baroreceptors in the pulmonary artery. Circ Res. 1962;10:664-667.
10. Baylen BG, Emmanouilides GC, Juratsch CE, Yoshida Y, French WJ, Criley JM. Main pulmonary artery distention: a potential mechanism for acute pulmonary hypertension in the human newborn infant. J Pediatr. 1980;96(3 pt 2):540-544.
11. Chen SL, Zhang YJ, Zhou L, Xie DJ, Zhang FF, Jia HB, Wong SS, Kwan TW. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention. 2013;9:269-276. doi: 10.4244/EIJV9I2A43.
12. Chen SL, Zhang FF, Xu J, Xie DJ, Zhou L, Nguyen T, Stone GW. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol. 2013;62:1092-1100. doi: 10.1016/j. jacc.2013.05.075.
13. Roehl AB, Steendijk P, Baumert JH, Schnoor J, Rossaint R, Hein M. Comparison of 3 methods to induce acute pulmonary hypertension in pigs. Comp Med. 2009;59:280-286.
14. Hameed AG, Arnold ND, Chamberlain J, Pickworth JA, Paiva C, Dawson S, Cross S, Long L, Zhao L, Morrell NW, Crossman DC, Newman CM, Kiely DG, Francis SE, Lawrie A. Inhibition of tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. J Exp Med. 2012;209:1919-1935. doi: 10.1084/jem.20112716.
15. Kummer W. Pulmonary vascular innervation and its role in responses to hypoxia: size matters! Proc Am Thorac Soc. 2011;8:471-476. doi: 10.1513/pats.201101-013MW.
16. Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR, Morrell NW. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 suppl):D4-D12. doi: 10.1016/j. jacc.2013.10.025.
17. de Man FS, Handoko ML, van Ballegoij JJ, Schalij I, Bogaards SJ, Postmus PE, van der Velden J, Westerhof N, Paulus WJ, Vonk-Noordegraaf A. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail. 2012;5:97-105. doi: 10.1161/CIRCHEARTFAILURE.111.964494.